To access this element change to forms mode OFF
Grant Award View - GA29716
Acute severe ulcerative colitis - clinical and translational studies
GA ID:
GA29716
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$128,225.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Acute severe ulcerative colitis - clinical and translational studies
Purpose:
Ulcerative colitis is a disease that causes damage to the lining of the bowel wall. Twenty percent of patients have a severe form of the condition. A third of patients do not get better with steroids and need infliximab, a stronger medication to help avoid emergency surgery to remove the large bowel. Our study aims to assess whether giving larger or more frequent doses of infliximab improves the chances of patients getting better and avoiding the need for surgery.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2019
Internal Reference ID:
GNT1168602
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA